Bristol-Myers Squibb Reconfigures Management, Will Evaluate All Operations
This article was originally published in The Gray Sheet
Executive Summary
The naming of a new executive to run Bristol-Myers Squibb's medical device business as part of a management restructuring announced Nov. 10 could foreshadow the eventual sale of the company's Zimmer orthopedics and ConvaTec ostomy products units.